A multicenter and post-marketing surveillance study to evaluate the safety and effectiveness of a sodium alginate-based raft-forming antacid oral suspension in Indian patients with heartburn and indigestion
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Background: This study evaluated the safety and effectiveness of a sodium alginate-based raft-forming antacid oral suspension in Indian patients with heartburn and indigestion. Methods: This multicenter post-marketing surveillance study, conducted across five centers in India, included adult patients with heartburn and indigestion prescribed a sodium alginate-based antacid suspension (10-20 ml after meals and at bedtime) for 7 days. Patients were evaluated on day 8 (±2). Effectiveness was assessed by adequate symptom relief, improvement in RDQ frequency and severity scores, reduction in symptom duration, and improvement in night-time symptoms. Safety was evaluated based on reported adverse drug reactions and global tolerability assessments by patients and investigators. Results: Of 319 enrolled patients, 297 completed the study. After 7 days, adequate relief was reported by 95.6% for heartburn and 96.6% for indigestion. RDQ frequency and severity scores significantly improved (both ~74-76% reduction; p
Fields of Study & Subjects
Gastroesophageal reflux and treatments
Gastrointestinal motility and disorders
Dental Erosion and Treatment
Publication details
- Journal / source
- International Journal of Research in Medical Sciences
- Volume
- 14
- Issue
- 4
- Pages
- 1518–1525
- Publication date
- 30 March 2026
- Language
- EN